Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease

ABSTRACT: Familial Alzheimer's disease (FAD) presenilin 1 E280A (PSEN1 E280A) is a severe neurological condition due to the loss of cholinergic neurons (ChNs), accumulation of amyloid beta (Aβ), and abnormal phosphorylation of the TAU protein. Up to date, there are no effective therapies availa...

Full description

Autores:
Giraldo Berrío, Daniela
Jiménez del Río, Marlene
Vélez Pardo, Carlos Alberto
Tipo de recurso:
Article of investigation
Fecha de publicación:
2024
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/42374
Acceso en línea:
https://hdl.handle.net/10495/42374
Palabra clave:
Enfermedad de Alzheimer
Alzheimer Disease
Apoptosis
Caspasa 3
Caspase 3
Proteína Desglicasa DJ-1
Protein Deglycase DJ-1
Péptidos beta-Amiloides
Amyloid beta-Peptides
Peróxido de Hidrógeno
Hydrogen Peroxide
Minociclina
Minocycline
https://id.nlm.nih.gov/mesh/D001618
https://id.nlm.nih.gov/mesh/D017209
https://id.nlm.nih.gov/mesh/D053148
https://id.nlm.nih.gov/mesh/D000071617
https://id.nlm.nih.gov/mesh/D016229
https://id.nlm.nih.gov/mesh/D006861
https://id.nlm.nih.gov/mesh/D008911
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_5c9f2e943df204b078b88e1cf772b84d
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/42374
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
title Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
spellingShingle Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
Enfermedad de Alzheimer
Alzheimer Disease
Apoptosis
Caspasa 3
Caspase 3
Proteína Desglicasa DJ-1
Protein Deglycase DJ-1
Péptidos beta-Amiloides
Amyloid beta-Peptides
Peróxido de Hidrógeno
Hydrogen Peroxide
Minociclina
Minocycline
https://id.nlm.nih.gov/mesh/D001618
https://id.nlm.nih.gov/mesh/D017209
https://id.nlm.nih.gov/mesh/D053148
https://id.nlm.nih.gov/mesh/D000071617
https://id.nlm.nih.gov/mesh/D016229
https://id.nlm.nih.gov/mesh/D006861
https://id.nlm.nih.gov/mesh/D008911
title_short Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
title_full Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
title_fullStr Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
title_full_unstemmed Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
title_sort Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
dc.creator.fl_str_mv Giraldo Berrío, Daniela
Jiménez del Río, Marlene
Vélez Pardo, Carlos Alberto
dc.contributor.author.none.fl_str_mv Giraldo Berrío, Daniela
Jiménez del Río, Marlene
Vélez Pardo, Carlos Alberto
dc.contributor.researchgroup.spa.fl_str_mv Grupo de Neurociencias de Antioquia
dc.subject.decs.none.fl_str_mv Enfermedad de Alzheimer
Alzheimer Disease
Apoptosis
Caspasa 3
Caspase 3
Proteína Desglicasa DJ-1
Protein Deglycase DJ-1
Péptidos beta-Amiloides
Amyloid beta-Peptides
Peróxido de Hidrógeno
Hydrogen Peroxide
Minociclina
Minocycline
topic Enfermedad de Alzheimer
Alzheimer Disease
Apoptosis
Caspasa 3
Caspase 3
Proteína Desglicasa DJ-1
Protein Deglycase DJ-1
Péptidos beta-Amiloides
Amyloid beta-Peptides
Peróxido de Hidrógeno
Hydrogen Peroxide
Minociclina
Minocycline
https://id.nlm.nih.gov/mesh/D001618
https://id.nlm.nih.gov/mesh/D017209
https://id.nlm.nih.gov/mesh/D053148
https://id.nlm.nih.gov/mesh/D000071617
https://id.nlm.nih.gov/mesh/D016229
https://id.nlm.nih.gov/mesh/D006861
https://id.nlm.nih.gov/mesh/D008911
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D001618
https://id.nlm.nih.gov/mesh/D017209
https://id.nlm.nih.gov/mesh/D053148
https://id.nlm.nih.gov/mesh/D000071617
https://id.nlm.nih.gov/mesh/D016229
https://id.nlm.nih.gov/mesh/D006861
https://id.nlm.nih.gov/mesh/D008911
description ABSTRACT: Familial Alzheimer's disease (FAD) presenilin 1 E280A (PSEN1 E280A) is a severe neurological condition due to the loss of cholinergic neurons (ChNs), accumulation of amyloid beta (Aβ), and abnormal phosphorylation of the TAU protein. Up to date, there are no effective therapies available. The need for innovative treatments for this illness is critical. We found that minocycline (MC, 5 μM) was innocuous toward wild-type (WT) PSEN1 ChLNs but significantly (i) reduces the accumulation of intracellular Aβ by -69%, (ii) blocks both abnormal phosphorylation of the protein TAU at residue Ser202/Thr205 by -33% and (iii) phosphorylation of the proapoptotic transcription factor c-JUN at residue Ser63/Ser73 by -25%, (iv) diminishes oxidized DJ-1 at Cys106-SO3 by -29%, (v) downregulates the expression of transcription factor TP53, (vi) BH-3-only protein PUMA, and (vii) cleaved caspase 3 (CC3) by -33, -86, and -78%, respectively, compared with untreated PSEN1 E280A ChLNs. Additionally, MC increases the response to ACh-induced Ca2+ influx by +92% in mutant ChLNs. Oxygen radical absorbance capacity (ORAC) and ferric ion-reducing antioxidant power (FRAP) analysis showed that MC might operate more efficiently as a hydrogen atom transfer agent than a single electron transfer agent. In silico molecular docking analysis predicts that MC binds with high affinity to Aβ (Vina Score -6.6 kcal/mol), TAU (VS -6.5 kcal/mol), and caspase 3 (VS -7.1 kcal/mol). Taken together, our findings suggest that MC demonstrates antioxidant, anti-amyloid, and anti-apoptosis activity and promotes physiological ACh-induced Ca2+ influx in PSEN1 E280A ChLNs. The MC has therapeutic potential for treating early-onset FAD.
publishDate 2024
dc.date.accessioned.none.fl_str_mv 2024-09-24T15:47:03Z
dc.date.available.none.fl_str_mv 2024-09-24T15:47:03Z
dc.date.issued.none.fl_str_mv 2024
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Giraldo-Berrío D, Jiménez-Del-Río M, Vélez-Pardo C. Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer's disease. Neuropharmacology. 2024 Sep 7;261:110152. doi: 10.1016/j.neuropharm.2024.110152.
dc.identifier.issn.none.fl_str_mv 0028-3908
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/42374
dc.identifier.doi.none.fl_str_mv 10.1016/j.neuropharm.2024.110152
dc.identifier.eissn.none.fl_str_mv 1873-7064
identifier_str_mv Giraldo-Berrío D, Jiménez-Del-Río M, Vélez-Pardo C. Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer's disease. Neuropharmacology. 2024 Sep 7;261:110152. doi: 10.1016/j.neuropharm.2024.110152.
0028-3908
10.1016/j.neuropharm.2024.110152
1873-7064
url https://hdl.handle.net/10495/42374
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Neuropharmacology
dc.relation.citationendpage.spa.fl_str_mv 16
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 261
dc.relation.ispartofjournal.spa.fl_str_mv Neuropharmacology
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
https://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 16 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.place.spa.fl_str_mv Oxford, Inglaterra
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/d3801f06-6d7a-4c55-9a72-4742d71abc43/download
https://bibliotecadigital.udea.edu.co/bitstreams/c463be06-4569-495b-823a-f875c6f5689d/download
https://bibliotecadigital.udea.edu.co/bitstreams/f89184f9-0f52-4b43-b7c2-da2baa2c6eaf/download
https://bibliotecadigital.udea.edu.co/bitstreams/1d1fe8b6-068c-43ff-bd68-fd9e02f7754b/download
https://bibliotecadigital.udea.edu.co/bitstreams/23e6b076-a330-4313-bda9-9a82fab7d937/download
bitstream.checksum.fl_str_mv 3305e939f37f877f3b8d919c6901c7ff
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
c871be45b68d1b9862af029b669e69d8
e651da129af7e5c2cbb9ff475c4e0ff1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052214268723200
spelling Giraldo Berrío, DanielaJiménez del Río, MarleneVélez Pardo, Carlos AlbertoGrupo de Neurociencias de Antioquia2024-09-24T15:47:03Z2024-09-24T15:47:03Z2024Giraldo-Berrío D, Jiménez-Del-Río M, Vélez-Pardo C. Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer's disease. Neuropharmacology. 2024 Sep 7;261:110152. doi: 10.1016/j.neuropharm.2024.110152.0028-3908https://hdl.handle.net/10495/4237410.1016/j.neuropharm.2024.1101521873-7064ABSTRACT: Familial Alzheimer's disease (FAD) presenilin 1 E280A (PSEN1 E280A) is a severe neurological condition due to the loss of cholinergic neurons (ChNs), accumulation of amyloid beta (Aβ), and abnormal phosphorylation of the TAU protein. Up to date, there are no effective therapies available. The need for innovative treatments for this illness is critical. We found that minocycline (MC, 5 μM) was innocuous toward wild-type (WT) PSEN1 ChLNs but significantly (i) reduces the accumulation of intracellular Aβ by -69%, (ii) blocks both abnormal phosphorylation of the protein TAU at residue Ser202/Thr205 by -33% and (iii) phosphorylation of the proapoptotic transcription factor c-JUN at residue Ser63/Ser73 by -25%, (iv) diminishes oxidized DJ-1 at Cys106-SO3 by -29%, (v) downregulates the expression of transcription factor TP53, (vi) BH-3-only protein PUMA, and (vii) cleaved caspase 3 (CC3) by -33, -86, and -78%, respectively, compared with untreated PSEN1 E280A ChLNs. Additionally, MC increases the response to ACh-induced Ca2+ influx by +92% in mutant ChLNs. Oxygen radical absorbance capacity (ORAC) and ferric ion-reducing antioxidant power (FRAP) analysis showed that MC might operate more efficiently as a hydrogen atom transfer agent than a single electron transfer agent. In silico molecular docking analysis predicts that MC binds with high affinity to Aβ (Vina Score -6.6 kcal/mol), TAU (VS -6.5 kcal/mol), and caspase 3 (VS -7.1 kcal/mol). Taken together, our findings suggest that MC demonstrates antioxidant, anti-amyloid, and anti-apoptosis activity and promotes physiological ACh-induced Ca2+ influx in PSEN1 E280A ChLNs. The MC has therapeutic potential for treating early-onset FAD.COL001074416 páginasapplication/pdfengElsevierOxford, Inglaterrahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s diseaseArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionEnfermedad de AlzheimerAlzheimer DiseaseApoptosisCaspasa 3Caspase 3Proteína Desglicasa DJ-1Protein Deglycase DJ-1Péptidos beta-AmiloidesAmyloid beta-PeptidesPeróxido de HidrógenoHydrogen PeroxideMinociclinaMinocyclinehttps://id.nlm.nih.gov/mesh/D001618https://id.nlm.nih.gov/mesh/D017209https://id.nlm.nih.gov/mesh/D053148https://id.nlm.nih.gov/mesh/D000071617https://id.nlm.nih.gov/mesh/D016229https://id.nlm.nih.gov/mesh/D006861https://id.nlm.nih.gov/mesh/D008911Neuropharmacology161261NeuropharmacologyPublicationORIGINALGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdfGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdfArtículo de investigaciónapplication/pdf12991689https://bibliotecadigital.udea.edu.co/bitstreams/d3801f06-6d7a-4c55-9a72-4742d71abc43/download3305e939f37f877f3b8d919c6901c7ffMD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/c463be06-4569-495b-823a-f875c6f5689d/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/f89184f9-0f52-4b43-b7c2-da2baa2c6eaf/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.txtGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.txtExtracted texttext/plain84504https://bibliotecadigital.udea.edu.co/bitstreams/1d1fe8b6-068c-43ff-bd68-fd9e02f7754b/downloadc871be45b68d1b9862af029b669e69d8MD54falseAnonymousREADTHUMBNAILGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.jpgGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.jpgGenerated Thumbnailimage/jpeg14651https://bibliotecadigital.udea.edu.co/bitstreams/23e6b076-a330-4313-bda9-9a82fab7d937/downloade651da129af7e5c2cbb9ff475c4e0ff1MD55falseAnonymousREAD10495/42374oai:bibliotecadigital.udea.edu.co:10495/423742025-03-26 18:43:28.227http://creativecommons.org/licenses/by-nc-nd/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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